Scholar Development Clinical Research (RMI)
Scholar Development Clinical Research (RMI)
批准号:
7690402
负责人:
Russell V Luepker
金额:
$362.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-23 至 2011-05-31
关键词:
ClassificationClinicClinicalClinical ResearchClinical TrialsCollaborationsCounty HospitalsDevelopmentDisciplineDiscipline of NursingDiseaseEpidemiologyFacultyFundingGeneral PopulationGoalsGrantHealthHumanIndustryInstitutionInternationalInvestmentsKnowledgeLaboratoriesLeadershipMedicineMentored Clinical Scientist Development ProgramMentorsMinnesotaMinorityNatureOutcomes ResearchPersonsPharmacologic SubstancePharmacy facilityPopulationPopulation HeterogeneityPostdoctoral FellowProductivityPublic HealthRecording of previous eventsResearch InfrastructureResearch PersonnelResearch Project GrantsResearch SupportResourcesSECTM1 geneSchool DentistrySchoolsStrategic PlanningStudentsSupport GroupsTrainingTraining ProgramsTranslatingUnited States Department of Veterans AffairsUnited States National Institutes of HealthUniversitiesWorkcareer developmentexperienceimprovedmedical specialtiesmultidisciplinaryprograms
中文摘要
从实验室获得的基本疾病机制的知识急剧增加,
床旁、诊所或一般人群。这些延误的部分原因是缺乏足够的训练有素的临床医生,
研究人员将科学发现转化为人类。认识到这一不足,大学
2003年,明尼苏达州卫生部及其学术健康中心(AHC)制定了一项战略计划,
研究(CR)在所有大学水平从本科生到高级教师。K12计划
该项目非常符合这些计划,并将加强明尼苏达州的CR投资。
该K12提案涵盖了从观察性流行病学到临床试验的CR范围,
成果研究。认识到CR的多学科性质,我们包括牙科学校,
医学,护理,药学和公共卫生在CR学者识别,培训和发展。
这些学科有着共同努力为CR提供领导的历史。从临床开始
专业研究员,博士后学生和初级教师,我们将选择CR学者参加目前的
以及正在进行的K30资助的新课程。由三人多学科导师团队提供建议,
包括一名生物统计学家在内,这些学者将获得AHC的大量资源和基础设施
包括:1)熟练、经验丰富、热情的高级导师; 2)具有国际
CR的声誉; 3)具有25年生产力记录的综合临床研究中心(GCRC); 4)A
5)退伍军人管理局和Hennepin县医院与不同的人口;
6)少数族裔招募计划; 7)联邦和行业资助的CR项目的实质性组合,以及;
8)拟议的共享临床研究支持小组。
AHC学校在多学科CR中使用团队方法进行合作的历史。这
该提案扩展了一家拥有十年战略投资计划的机构中成功的CR企业。
我们的目标是通过CR改善健康和治疗疾病。这一建议将许多大学合并,
明尼苏达州的优势是为NIH CR学者提供系统的,有重点的职业发展培训计划。
英文摘要
Dramatic increases in the knowledge of basic disease mechanisms from the laboratory are slow to find the
bedside, clinic or general population. These delays are due,in part, to a lack of enough well-trained clinical
researchers to translate scientific discoveries in human populations. Recognizing this deficit, the University
of Minnesota and its Academic Health Center (AHC) developed a strategic plan in 2003 prioritizing clinical
research (CR) at all University levels from undergraduates to the senior faculty. The proposed K12 program
fits well into those plans and will enhance the substantial Minnesota CR investment.
This K12 proposal embraces the spectrum of CR from observational epidemiology to clinical trials to
outcomes research. Recognizing the multidisciplinary nature of CR, we include the Schools of Dentistry,
Medicine, Nursing, Pharmacy and Public Health in CR scholar identification, training and development.
These disciplines have a history of working together to provide leadership for CR. Beginning with clinical
specialty fellows, postdoctoral students and junior faculty, we will select CR scholars to participate in current
and new coursework from an ongoing K30 grant. Advised by three-person multidisciplinary mentor teams,
including a biostatistician, the scholars will access substantial resources and infrastructure in the AHC
including: 1) Skilled, experienced and enthusiastic senior mentors; 2) Biostatisticians with an international
reputation for CR; 3) A General Clinical Research Center (GCRC) with a 25-year record of productivity; 4) A
pharmaceutical center; 5) Veterans Administration and Hennepin County hospitals with diverse populations;
6) A minority recruitment program; 7) A substantial portfolio of federal and industry funded CR projects,and;
8) A proposed Shared Clinical Research Support Group.
There is a history of collaboration among AHC schools in multidisciplinary CR using a team approach. This
proposal expands on a successful CR enterprise in an institution with a ten-year strategic investment plan.
The goal is to improve health and cure diseases through CR. This proposal merges many University of
Minnesota strengths in a systematic, focused career development training program for NIH CR scholars.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/pcan.2011.27
发表时间:
2011-09
期刊:
PROSTATE CANCER AND PROSTATIC DISEASES
影响因子:
4.8
作者:
[Elliott, S. P., Wilt, T. J., Kuntz, K. M.]
通讯作者:
Kuntz, K. M.
DOI:
10.14219/jada.archive.2012.0301
发表时间:
2012-08
期刊:
Journal of the American Dental Association (1939)
影响因子:
--
作者:
[Svensson P, Drangsholt M, Pfau DB, List T]
通讯作者:
List T
Intramuscular and intravenous levetiracetam in humans: safety and pharmacokinetics.
人体肌肉注射和静脉注射左乙拉西坦:安全性和药代动力学。
DOI:
10.1016/j.eplepsyres.2010.07.016
发表时间:
2010
期刊:
Epilepsy research
影响因子:
2.2
作者:
[Leppik,IloE, Goel,Varun, Rarick,John, Nixdorf,DonaldR, Cloyd,JamesC]
通讯作者:
Cloyd,JamesC
DOI:
10.1097/coh.0b013e328329c62f
发表时间:
2009-05
期刊:
Current opinion in HIV and AIDS
影响因子:
4.1
作者:
[Baker JV, Henry WK, Neaton JD]
通讯作者:
Neaton JD
Pre- and postmarathon training habits of nonelite runners.
非精英跑者马拉松前后的训练习惯。
DOI:
10.2147/oajsm.s16665
发表时间:
2011
期刊:
Open access journal of sports medicine
影响因子:
2.4
作者:
[Voight,AngelaM, Roberts,WilliamO, Lunos,Scott, Chow,LisaS]
通讯作者:
Chow,LisaS
共 21 条
Testing a Community Intervention to Increase Aspirin Use for Primary Prevention of Cardiovascular Disease
-
批准号:8808639
-
项目类别:
-
资助金额:$74.33万
-
财政年份:2014
-
负责人:Russell V Luepker
-
依托单位:
Testing a Community Intervention to Increase Aspirin Use for Primary Prevention of Cardiovascular Disease
-
批准号:9187044
-
项目类别:
-
资助金额:$71.33万
-
财政年份:2014
-
负责人:Russell V Luepker
-
依托单位:
Testing a Community Intervention to Increase Aspirin Use for Primary Prevention of Cardiovascular Disease
-
批准号:8975801
-
项目类别:
-
资助金额:$69.36万
-
财政年份:2014
-
负责人:Russell V Luepker
-
依托单位:
Midwest Consortium for Clinical/Translational Education & Research Collaboration
-
批准号:7912763
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2010
-
负责人:Russell V Luepker
-
依托单位:
Midwest Consortium for Clinical/Translational Education & Research Collaboration
-
批准号:8073080
-
项目类别:
-
资助金额:$1.98万
-
财政年份:2010
-
负责人:Russell V Luepker
-
依托单位:
Scholar Development Clinical Research (RMI)
-
批准号:7292669
-
项目类别:
-
资助金额:$318.65万
-
财政年份:2005
-
负责人:Russell V Luepker
-
依托单位:
Scholar Development Clinical Research (RMI)
-
批准号:7050380
-
项目类别:
-
资助金额:$154.0万
-
财政年份:2005
-
负责人:Russell V Luepker
-
依托单位:
Scholar Development Clinical Research (RMI)
-
批准号:7493462
-
项目类别:
-
资助金额:$363.96万
-
财政年份:2005
-
负责人:Russell V Luepker
-
依托单位:
Scholar Development Clinical Research (RMI)
-
批准号:7169530
-
项目类别:
-
资助金额:$154.12万
-
财政年份:2005
-
负责人:Russell V Luepker
-
依托单位:
Ancel Keys Symposium on Nutrition and Health: Obesity
-
批准号:6887859
-
项目类别:
-
资助金额:$0.2万
-
财政年份:2004
-
负责人:Russell V Luepker
-
依托单位:
MINNESOTA STROKE SURVEY
-
批准号:6394197
-
项目类别:
-
资助金额:$55.68万
-
财政年份:2000
-
负责人:Russell V Luepker
-
依托单位:
COMMUNITY SURVEILLANCE OF CHD AND SUDDEN DEATH (MHS)
-
批准号:6200187
-
项目类别:
-
资助金额:$54.9万
-
财政年份:2000
-
负责人:Russell V Luepker
-
依托单位:
COMMUNITY SURVEILLANCE OF CHD AND SUDDEN DEATH (MHS)
-
批准号:6537895
-
项目类别:
-
资助金额:$65.33万
-
财政年份:2000
-
负责人:Russell V Luepker
-
依托单位:
COMMUNITY SURVEILLANCE OF CHD AND SUDDEN DEATH (MHS)
-
批准号:6769932
-
项目类别:
-
资助金额:$20.77万
-
财政年份:2000
-
负责人:Russell V Luepker
-
依托单位:
MINNESOTA STROKE SURVEY
-
批准号:6606915
-
项目类别:
-
资助金额:$65.43万
-
财政年份:2000
-
负责人:Russell V Luepker
-
依托单位:
CLINICAL RESEARCH CURRICULUM AWARD
-
批准号:6785366
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2000
-
负责人:Russell V Luepker
-
依托单位:
COMMUNITY SURVEILLANCE OF CHD AND SUDDEN DEATH (MHS)
-
批准号:6390904
-
项目类别:
-
资助金额:$65.0万
-
财政年份:2000
-
负责人:Russell V Luepker
-
依托单位:
MINNESOTA STROKE SURVEY
-
批准号:6131084
-
项目类别:
-
资助金额:$44.98万
-
财政年份:2000
-
负责人:Russell V Luepker
-
依托单位:
COMMUNITY SURVEILLANCE OF CHD AND SUDDEN DEATH (MHS)
-
批准号:6603875
-
项目类别:
-
资助金额:$51.05万
-
财政年份:2000
-
负责人:Russell V Luepker
-
依托单位:
MINNESOTA STROKE SURVEY
-
批准号:6802736
-
项目类别:
-
资助金额:$48.4万
-
财政年份:2000
-
负责人:Russell V Luepker
-
依托单位:
海外基金